Table 3.
Overview of countries using pay-for-performance elements to achieve specific goals.
| Work force capacity | Provider activity | Provider mobility | Vaccination outcome | |
|---|---|---|---|---|
| Australia | X | X | X | X |
| Czech Republic | X | |||
| Denmark | X | |||
| Estonia | X | |||
| France | X | X | ||
| Germany | X | |||
| Greece | X | |||
| Italy | X | |||
| Japan | X | X | ||
| Latvia | X | |||
| Lithuania | X | |||
| Netherlands | X | |||
| New Zealand | X | |||
| Norway | X | |||
| Poland | X | |||
| Romania | X | |||
| Slovak Republic | X | |||
| Slovenia | X | |||
| UK – England | X | (X) | ||
| UK – Wales | X | |||
| United States – (Medicare) | X | (X) | ||
| Total | 8 | 4 | 13 | 1 |
“X” indicates presence of pay-for-performance scheme, brackets indicate that the country retired the policy. Note: We only included pay-for-performance elements that were introduced to pay for vaccinations against SARS-CoV-2.